The next donor recruitment drives for the Marshall's Match campaign are being held this weekend - with one taking place at ...

Drug coverage for four drugs used to treat some rare diseases was announced in Fredericton on Wednesday under a $32-million ...

In the study, 69 patients with cutaneous T-cell lymphoma, including the most common subtypes mycosis fungoides and Sézary syndrome, were given DD-cxdl for five consecutive days every 21 days.

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable.  Canadians deserve a health care system that provides timely access to quality ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®? (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a ...

Mycosis Fungoides Market Outlook 2025-2035: The mycosis fungoides market is demonstrating a promising trajectory, with a projected CAGR of 5.1% across the 7 major markets between 2025 and 2035. The ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.

A benefit is planned for Saturday at 1 pm at the Corner Pub in Tomahawk. There will be raffles, prizes, silent auctions, and free food. All alcohol sold that day will be donated to Christopher and his ...

and escape signs -to have a certificate of mycosis and disinfestation, a pharmacy with first aid supplies as well as a guide ...